In a blast from markets past, one cannabis company saw a massive value increase last Thursday (October 17) based on little to no material activity, besides a new review.

Shares of Cronos Group (NASDAQ:CRON,TSX:CRON) spiked last week by over 20 percent on the eve of Canada’s second stage of legalization. Called Cannabis 2.0, it made the production, sale and consumption of cannabis-infused edibles legal.

Cronos saw an increase of 25.8 percent from its closing price of C$11.03 last Wednesday (October 16), hitting C$13.87 on Thursday in Toronto.

Since then, activity has settled down and prices for the producer have returned to their previous level. At market open on Monday (October 21) shares of Cronos were at C$10.82.

According to Markets Insider, data from Bloomberg shows that a series of significant block trades of Cronos on the NADSAQ led to a boost for the stock during the after-hours trading period last Wednesday.

The stock jumped after two separate block trades, one for 810,000 shares and the second for 350,000 shares, both priced at US$8.40 per share. Later, these were followed by two more large share trades at US$11.50 per share.

The company was lauded last week by one analyst who, in the tradition of the hit TV show Game of Thrones, crowned Cronos as the new “king in the north.”

In a note to clients released on Friday (October 18), Stifel analyst W. Andrew Carter raised Cronos to a “buy” rating from a “hold” while dropping his price target to C$14 from C$16.50.

Carter said the industry is in a “sector meltdown,” and noted that this factor, along with underwhelming results from Cronos, has placed the Ontario producer at a discount compared to its peers.

Carter said Cronos’ profile was enhanced by a C$2.4 billion equity investment from American tobacco company Altria Group (NYSE:MO) in March. Altria now has a 45 percent ownership interest in Cronos.

“We believe renewed investor enthusiasm is inevitable as we consider the C$200 billion global opportunity driven by regulatory and demographic tailwinds,” Carter wrote to investors.

The analyst also believes Cronos will leverage its connection to Altria to build out its cannabidiol business in the US and to help it improve its product potential in the Canadian vaporizer market.

The vapor segment is set to create big business for Cronos, according to Stifel, who projects C$450 million in sales in 2021 for the company, driven largely by the market for cannabis vaporizers.

Carter said the firm is “unconstrained” in its ability to make investments of its own as it has C$2 billion in cash on hand.

In its earnings report for Q2 2019, Cronos achieved net revenue at C$10.2 million, up 202 percent from the same quarter last year.

The stock is currently listed as a “moderate buy” on TipRanks, with five “buy” ratings and an average price target of C$15.01.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure

Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less